Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TENUVA-BP: Telmisartan/S-Amlodipine vs Telmisartan in Hypertension
NCT02231788Phase 4Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Jun 2014
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Levamlodipine in hypertension (HTN) (2 arms), sponsored by Chong Kun Dang Holdings. Primary endpoint: Change from baseline in the 24hr mean blood pressure by ambulatory blood pressure monitoring (ABPM) at 8 weeks. Started Jun 2014; status: completed.
02
Drugs
Levamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02231788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02231788.